DDA1 promotes stage IIB–IIC colon cancer progression by activating NFκB/CSN2/GSK-3β signaling

Conventional high-recurrence risk factors are not sufficient to predict post-operative risk of tumor recurrence or sensitivity to 5-fluorouracil (5-FU)-based chemotherapy for stage II colon cancer. DDA1, an evolutionarily conserved gene located at 19p13.11, may be involved in the activation of nucle...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Senlin, Tang, Huamei, Yan, Dongwang, Fan, Junwei, Sun, Hongcheng, Wen, Yugang, Yu, Fudong, Cui, Feifei, Zhang, Dongyuan, Xue, Yingming, Liu, Chenchen, Yue, Ben, Chen, Jian, Wang, Jingtao, Wang, Xiao, Zhang, Meng, Yu, Yang, Jiang, Weiliang, Liu, Xisheng, Mi, Yushuai, Zhou, Zongguang, Qin, Xuebin, Peng, Zhihai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991419/
https://www.ncbi.nlm.nih.gov/pubmed/26942699
http://dx.doi.org/10.18632/oncotarget.7847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991419/
https://www.ncbi.nlm.nih.gov/pubmed/26942699
http://dx.doi.org/10.18632/oncotarget.7847

Ejemplares similares